GARRETT WRAY: Open Payments
NPI 1063957546 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,796 in 101 payments from 14 companies in 2025. Trend: 2023 $1,592 · 2024 $1,356 · 2025 $1,796
Food & beverage: $1,796
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $402 |
| AstraZeneca Pharmaceuticals LP | 15 | $395 |
| PFIZER INC. | 17 | $225 |
| ABBVIE INC. | 12 | $166 |
| Amgen Inc. | 6 | $163 |
| Lilly USA, LLC | 11 | $134 |
| Otsuka America Pharmaceutical, Inc. | 5 | $84 |
| Phathom Pharmaceuticals, Inc. | 6 | $51 |
| Abbott Laboratories | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
Products named: AIRSUPRA, Ozempic, Wegovy, EVENITY, NURTEC ODT, UBRELVY, MOUNJARO, REXULTI.
Industry payments across AR — which companies pay providers there.
